Selected Information by Business Segment |
Selected information by reportable segment is presented below: | | | | | | | | | | | | | | | | | Three Months Ended | | | | | | June 28, 2025 | | June 29, 2024 | | | | | | | | | | | | | | (Dollars in Thousands) | | | | | Net revenues: | | | | | | | | Plasma | $ | 129,897 | | | $ | 135,910 | | | | | | Blood Center | 51,839 | | | 66,245 | | | | | | Hospital | 139,658 | | | 134,017 | | | | | | Total net revenues | $ | 321,394 | | | $ | 336,172 | | | | | | | | | | | | | | Significant segment expenses and operating performance: | | | | | | | | Plasma | | | | | | | | Cost of goods sold | $ | 49,917 | | | $ | 65,338 | | | | | | Selling, general and administrative | 26,198 | | | 25,130 | | | | | | Research and development | 5,497 | | | 3,719 | | | | | | Plasma operating income | $ | 48,285 | | | $ | 41,723 | | | | | | Blood Center | | | | | | | | Cost of goods sold | $ | 25,948 | | | $ | 36,180 | | | | | | Selling, general and administrative | 13,682 | | | 15,602 | | | | | | Research and development | 1,319 | | | 1,684 | | | | | | Blood Center operating income | $ | 10,890 | | | $ | 12,779 | | | | | | Hospital | | | | | | | | Cost of goods sold | $ | 50,216 | | | $ | 48,685 | | | | | | Selling, general and administrative | 62,323 | | | 61,190 | | | | | | Research and development | 8,742 | | | 7,623 | | | | | | Hospital operating income | $ | 18,377 | | | $ | 16,519 | | | | | | Corporate and unallocated expenses | | | | | | | | Amortization of acquired intangible assets | $ | (13,828) | | | $ | (17,710) | | | | | | Acquisition, integration and divestiture related costs | (2,682) | | | (12,323) | | | | | | Restructuring and restructuring related costs | (1,324) | | | (7,140) | | | | | | Digital transformation costs | (5,355) | | | (6,345) | | | | | | Remeasurement of contingent consideration | 93 | | | — | | | | | | Other(1) | (584) | | | 12,253 | | | | | | Operating income | 53,872 | | | 39,756 | | | | | | Interest and other (expense) income, net | (8,703) | | | 6,957 | | | | | | Income before provision for income taxes | $ | 45,169 | | | $ | 46,713 | | | | | |
|
Schedule of Revenues by Business Unit and Geographic Regions |
Net revenues by business unit are as follows: | | | | | | | | | | | | | | | | | Three Months Ended | | | | June 28, 2025 | | June 29, 2024 | | | | | | | | | | | | | | (Dollars in Thousands) | | | | | Plasma | | | | | | | | Plasma net revenues | $ | 129,897 | | | $ | 135,910 | | | | | | | | | | | | | | Blood Center | | | | | | | | Apheresis | 51,822 | | | 49,094 | | | | | | Whole Blood | 17 | | | 17,151 | | | | | | Blood Center net revenues | 51,839 | | | 66,245 | | | | | | | | | | | | | | Hospital | | | | | | | | Interventional Technologies | 58,483 | | | 63,044 | | | | | | Blood Management Technologies | 81,175 | | | 70,973 | | | | | | Hospital net revenues | 139,658 | | | 134,017 | | | | | | | | | | | | | | Total net revenues | $ | 321,394 | | | $ | 336,172 | | | | | |
Depreciation and amortization, excluding impairment charges, by business unit are as follows: | | | | | | | | | | | | | | | | | Three Months Ended | | | | June 28, 2025 | | June 29, 2024 | | | | | | | | | | | | | | (Dollars in Thousands) | | | | | Plasma | $ | 12,153 | | | $ | 11,916 | | | | | | Blood Center | 1,759 | | | 3,453 | | | | | | Hospital | 14,846 | | | 13,767 | | | | | | Total depreciation and amortization (excluding impairment charges) | $ | 28,758 | | | $ | 29,136 | | | | | |
Long-lived assets, comprised of property, plant and equipment, by business unit are as follows: | | | | | | | | | | | | | June 28, 2025 | | March 29, 2025 | | | | | | (Dollars in Thousands) | Plasma | $ | 193,740 | | | $ | 189,833 | | Blood Center | 38,412 | | | 40,337 | | Hospital | 54,713 | | | 53,882 | | Total long-lived assets | $ | 286,865 | | | $ | 284,052 | |
Long-lived assets, comprised of property, plant and equipment, by operating regions are as follows: | | | | | | | | | | | | | June 28, 2025 | | March 29, 2025 | | | | | | (Dollars in Thousands) | United States | $ | 213,834 | | | $ | 217,212 | | Japan | 1,228 | | | 1,250 | | Europe | 24,177 | | | 20,024 | | Rest of Asia | 29,828 | | | 28,705 | | Other | 17,798 | | | 16,861 | | Total long-lived assets | $ | 286,865 | | | $ | 284,052 | |
Net revenues by operating regions are as follows: | | | | | | | | | | | | | | | | | Three Months Ended | | | | June 28, 2025 | | June 29, 2024 | | | | | | | | | | | | | | (Dollars in Thousands) | | | | | United States | $ | 242,404 | | | $ | 248,902 | | | | | | Japan | 13,648 | | | 13,705 | | | | | | Europe | 40,882 | | | 47,225 | | | | | | Rest of Asia | 21,648 | | | 19,783 | | | | | | Other | 2,812 | | | 6,557 | | | | | | Total net revenues | $ | 321,394 | | | $ | 336,172 | | | | | |
|